NR4A1 and breast carcinoma: First, the lack of sufficient data provided in reports restricted further evaluation of potential associations between the RARβ2 methylation and other confounding factors, such as age, hormone receptor status and subtype of breast cancer, which might be sources of the heterogeneity.